Rheum KPs Flashcards

(63 cards)

1
Q

Pain with both passive and active range of motion implies?

pain with only active range of motion is likely due to?

A

an intrinsic joint condition,

a periarticular condition.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Synovial fluid leukocyte counts - normal? non-inflammatory conditions? inflammatory states?

A

<200

200-2000

> 2000

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Meds that provide similar pain relief for inflammatory conditions as oral NSAIDs with fewer gastrointestinal effects and are preferred for patients 75 years or older

A

topical NSAIDs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

When should patients on steroids get bisphosphonate therapy?

A

> 4 weeks at doses >5 mg prednisone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Non-Biologic DMARDs?

A

Chasm Clam

Cyclophosphamide
Hydroxychloroquine
Azathioprine
Sulfasalazine
Methotrexate

Cyclosporine
Leflunomide
Apremilast
Mycophenolate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

recommended initial disease-modifying antirheumatic drug for most patients?

A

Methotrexate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Cyclophosphamide is used to treat?

A

severe and/or life-threatening manifestations SLE

systemic sclerosis, the inflammatory myopathies, interstitial lung disease, and vasculitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Perk of mycophenolate mofetil?

A

at least as effective as cyclophosphamide for systemic lupus erythematosus but with fewer, and milder, side effects.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

If non-biologics fail, first choice of biologics?

A

TNF-a inhibitors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

vaccines are currently contraindicated for patients on biologic therapies? When should they be given?

A

Live attenuated

4 weeks before starting

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Allopurinol MoA? Avoid in which patients?

A

purine analogue that inhibits xanthine oxidase; other purine analogues (azathioprine or 6MP)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Feboxustat MoA? Benefit over allopurinol? Avoid in which patients?

A

non-purine, non-competitive xanthine oxidase inhibitor; less likely to cause hypersensitivity

other purine analogues (azathioprine or 6MP)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Probenecif MoA? Avoid in patients with?

A

promotes kidney uric acid excretion (uricosuric effect)

CrCl<50

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Imaging used to follow course of RA?

Imaging that should not be routinely preformed?

A

Plain radiography of the hands, wrists, and/or feet

MRI of peripheral joints

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Felty Syndrome?

A

Neutropenia, splenomegaly, and RA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

recommended initial disease-modifying antirheumatic drug for most patients with rheumatoid arthritis?

A

Methotrexate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Benefits of TNF-a inhibitor in psoriatic arthritis?

A

remission, reduces radiographic progression, nromalizes acute phase reactants, reduce cardiovascular risk

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

RA drugs contraindicated in pregnancy? Safe in pregnancy?

A

Methotrexate and leflunomide are absolutely contraindicated in pregnancy

Both hydroxychloroquine and sulfasalazine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

radiographic hallmarks of osteoarthritis?

In contrast, radiographic findings seen in RA (which are absent in OA)?

A

Joint-space narrowing, subchondral sclerosis, and marginal osteophyte formation

periarticular osteopenia and marginal erosions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Intra-articular glucocorticoids reduce osteoarthritis knee pain within?

A

days to weeks

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

The most effective surgical intervention for knee or hip osteoarthritis?

A

total joint arthroplasty

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Fibromyalgia is a clinical diagnosis characterized by?

A
  • chronic widespread pain,
  • tenderness of the skin and muscles to pressure,
  • fatigue,
  • sleep disturbance, and
  • exercise intolerance.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Initial laboratory evaluation of fibromyalgia?

Tests that should be avoided?

A

BMP, CBC TSH, ESR, CRP

ANA, RF, anti-CCP, CK

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

For patients with fibromyalgia, this is critical for functional improvement.

A

aerobic exercise

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
FDA approved and modestly effective for fibromyalgia? (3)
Pregabalin, duloxetine, and milnacipran
26
Severe presentations of reactive arthritis or psoriatic arthritis should raise concern for?
HIV
27
Arthritis of varying patterns may occur in patients with IBD, but this type parallels IBD activity?
oligoarticular peripheral arthritis
28
spondyloarthritis - 1st line imaging? Role of MRI? Role of CT?
XR only if conventional radiographs are negative and strong suspicion only for identifying occult spine fractures and bony erosions.
29
first-line therapy for ankylosing spondylitis? If inadequate?
NSAIDs TNF-a inhibitors
30
first-line therapy for psoriatic arthritis? If inadequate?
NSAIDs for inflammation; non-biologic DMARDs for arthritis and enthesitis biologics
31
first-line therapy for inflammatory bowel disease–associated arthritis? If inadequate?
Methotrexate or sulfasalazine TNF-a
32
All patients with systemic lupus erythematosus should be evaluated for nephritis with?
Cr, Urine protein-creatinine ratio, urinalysis
33
Most common cause of death for older patients with SLE?
ischemic heart disease
34
Anti-U1? (3)
Associated with Raynaud phenomenon and esophageal dysmotility; also seen in MCTD
35
Antiribosomal P?
Associated with CNS lupus and lupus hepatitis
36
Med that should be initiated in every patient with systemic lupus erythematosus who can tolerate?
Hydroxychloroquine
37
initial therapy for acute manifestations of systemic lupus erythematosus?
Steroids
38
Maternal antibodies associated with neonatal lupus erythematosus?
anti-Ro/SSA or anti-La/SSB
39
Patients with Sjögren syndrome have a ~30-fold increased risk for? (most common type?)
lymphoma (DLBCL and MALT)
40
If diagosis of Sjögren syndrome is unclear, can biopsy?
lip biopsy demonstrating minor salivary gland inflammation
41
Prognosis of MCTD v SLE? Why?
Increased. PAH more common in MCTD
42
“treat-to-target” approach for gout - targets?
<6.0 in patients without tophi | <5.0 in patients with tophi
43
Gout flare prophylaxis?
colchicine and NSAIDs
44
Calcium pyrophosphate deposition is associated with these diseases?
hyperparathyroidism, hemochromatosis, hypomagnesemia, and hypothyroidism
45
Management of symptomatic basic calcium phosphate deposition (Milwaukee shoulder syndrome?)
NSAIDS, joint aspiration adn tidal lavage, and intra-articular steroids
46
disseminated gonococcal infection present with these two syndromes
1) arthritis, tenosynovitis, and dermatitis | 2) purulent monoarthritis or oligoarthritis.
47
Musculoskeletal Mycobacterium tuberculosis typically presents as?
spondylitis, vertebral osteomyelitis, or hip or knee arthritis. - NO CONSTITUTIONAL SYMPTOMS
48
nterstitial lung disease in patients with dermatomyositis or polymyositis is associated with these antibodies?
with antisynthetase antibodies, including anti–Jo-1
49
pt with dermatomyositis or polymyositis - cancer screening?
age-appropriate + ovarian (no CT or PET unless additional risk factors)
50
Treatment of polyarteritis nodosa includes?
high-dose prednisone and cyclophosphamide.
51
Primary angiitis of the central nervous system presents with?
recurrent headaches and progressive encephalopathy
52
Kawasaki disease symptoms?
high spiking fevers, conjunctivitis, rash, and mucositis of the lips and oral cavity.
53
Microscopic polyangiitis typically involves? patients classically express?
the kidneys and lungs p-ANCA and antimyeloperoxidase (MPO)
54
Remission induction of both granulomatosis with polyangiitis and microscopic polyangiitis consists of?
high-dose glucocorticoids plus cyclophosphamide or rituximab, followed by maintenance therapy
55
characteristic rash in type II cryoglobulinemia? Other organs involved?
Palpable purpura; Peripheral nerves and kidneys
56
Diffuse cutaneous systemic sclerosis is characterized by?
extensive distal and proximal skin thickening (chest, abdomen, and arms proximal to wrists) and is commonly accompanied by internal organ fibrosis.
57
Limited cutaneous systemic sclerosis is characterized by ?
distal (face, neck, and hands), but not proximal, skin thickening; it is usually unaccompanied by internal organ fibrosis but is more likely to be associated with pulmonary arterial hypertension.
58
autoantibody testing for systemic sclerosis?
antinuclear, anti–Scl-70, anticentromere, and anti-RNA polymerase III
59
How to distinguish secondary Raynaud phenomenon associated with systemic sclerosis from primary Raynaud phenomenon?
Nailfold capillarioscopy (abnormal in systemic sclerosis)
60
Med that decreases mortality among patients with scleroderma renal crisis
ACE inhibitor
61
annual monitoring of this is recommended for all patients with systemic sclerosis?
PAH
62
Relapsing polychondritis is characterized by? (4)
- chondritis of the ears, nose, and/or respiratory tract; - nonerosive inflammatory polyarthritis; - ocular inflammation; - cochlear and/or vestibular dysfunction.
63
Relapsing polychondritis - ear findings?
Spares earlobe